Steve Nicholson
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
Papers in
- Surgery 12
- Genital Health and Disease 9
- Bladder and Urothelial Cancer Treatments 3
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Emma Hall (8 shared papers)Amit Bahl (7 shared papers)Poulam M. Patel (1 shared paper)A.B. Alexandroff (1 shared paper)Andrew M. Jackson (1 shared paper)Paul Nathan (8 shared papers)Angus Dalgleish (3 shared papers)Ian Clarke (2 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (4 papers)The Lancet Oncology (2 papers)British Journal of Urology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Steve Nicholson
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 75
- Oncology 271
- Immunology 164
- Urology 37
- Genetics 64
- Surgery 255
Countries citing papers authored by Steve Nicholson
This map shows the geographic impact of Steve Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Nicholson more than expected).
Fields of papers citing papers by Steve Nicholson
This network shows the impact of papers produced by Steve Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Nicholson. The network helps show where Steve Nicholson may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Nicholson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 126 | |
| 2 | 2013 | 87 | |
| 3 | 2012 | 87 | |
| 4 | 2014 | 75 | |
| 5 | 1998 | 70 | |
| 6 | 2010 | 64 | |
| 7 | 2002 | 61 | |
| 8 | A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. | 1997 | 60 |
| 9 | 1999 | 54 | |
| 10 | 2019 | 49 | |
| 11 | Placental site trophoblastic tumor: molecular analysis and clinical experience. | 1996 | 45 |
| 12 | 2004 | 34 | |
| 13 | 2013 | 27 | |
| 14 | 2004 | 26 | |
| 15 | 2010 | 24 | |
| 16 | 2003 | 22 | |
| 17 | 2011 | 15 | |
| 18 | 2009 | 12 | |
| 19 | 2018 | 12 | |
| 20 | 2009 | 12 |
About Steve Nicholson
Steve Nicholson is a scholar working on Surgery, Molecular Biology, Oncology, Pediatrics, Perinatology and Child Health and Immunology, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genital Health and Disease (9 papers), Urologic and reproductive health conditions (3 papers), Renal cell carcinoma treatment (3 papers), Cancer Genomics and Diagnostics (3 papers), Urological Disorders and Treatments (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Ethics and Legal Issues in Pediatric Healthcare (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (271 citations), Immunology (164 citations), Urology (37 citations), Genetics (64 citations) and Surgery (255 citations). Steve Nicholson has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Emma Hall, Amit Bahl, Poulam M. Patel, A.B. Alexandroff, Andrew M. Jackson, Paul Nathan, Angus Dalgleish, Ian Clarke, Agamemnon A. Epenetos and Jerome B. Zeldis. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, The Lancet Oncology, British Journal of Urology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.